Shepherd Kaplan Krochuk’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-243
Closed -$186K 274
2017
Q4
$186K Sell
243
-186
-43% -$144K 0.12% 190
2017
Q3
$361K Sell
429
-20
-4% -$16.7K 0.3% 99
2017
Q2
$404K Sell
449
-74
-14% -$62.9K 0.24% 95
2017
Q1
$468K Hold
523
0.24% 86
2016
Q4
$543K Buy
523
+177
+51% +$183K 0.15% 79
2016
Q3
$687K Sell
346
-8
-2% -$14.9K 0.14% 89
2016
Q2
$602K Hold
354
0.15% 91
2016
Q1
$619K Sell
354
-357
-50% -$568K 0.19% 83
2015
Q4
$1.25M Buy
711
+10
+1% +$17.7K 0.33% 48
2015
Q3
$1.2M Sell
701
-136
-16% -$328K 0.32% 50
2015
Q2
$2.27M Sell
837
-39
-4% -$101K 0.43% 37
2015
Q1
$2.53M Sell
876
-66
-7% -$183K 0.45% 33
2014
Q4
$2.47M Buy
942
+54
+6% +$140K 0.4% 50
2014
Q3
$2.44M Buy
888
+2
+0.2% +$6.5K 0.31% 50
2014
Q2
$3.06M Hold
886
0.32% 49
2014
Q1
$3.22M Sell
886
-60
-6% -$236K 0.37% 45
2013
Q4
$3.57M Sell
946
-94
-9% -$338K 0.45% 39
2013
Q3
$3.39M Sell
1,040
-67
-6% -$196K 0.55% 34
2013
Q2
$2.8M Buy
+1,107
New +$2.75M 0.55% 34

Other funds holding TRIB

Shepherd Kaplan Krochuk's TRIB Position: Q1 2018 in Review

Shepherd Kaplan Krochuk sold out of Trinity Biotech (TRIB) in Q1 2018, closing a stake of 243 shares — an estimated $186K sold.

Shepherd Kaplan Krochuk first reported a position in TRIB in Q2 2013 and held it in 19 quarters. The position peaked at $3.57M in Q4 2013. 44 funds tracked by Wall St. Rank hold TRIB as of Q1 2018.

  • Shepherd Kaplan Krochuk reported no remaining Trinity Biotech position as of Q1 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 243 Trinity Biotech shares in Q1 2018, an estimated $186K.
  • Shepherd Kaplan Krochuk first reported a position in Trinity Biotech in Q2 2013 and held it in 19 quarters.
  • Shepherd Kaplan Krochuk's Trinity Biotech position peaked at $3.57M in Q4 2013.
  • 44 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2018, filed 11 May 2018.